Soho Global Health Overview
- Year Founded
-
1956
- Status
-
Public
- Employees
-
2,329
- Stock Symbol
-
SOHO
- Share Price
-
$0.06
- (As of Wednesday Closing)
Soho Global Health General Information
Description
PT Soho Global Health Tbk is a healthcare company operating in the areas of natural/herbal health care products and services. The company manufactures and distributes pharmaceutical products, including herbal cures, proprietary medicines, and health foods, under various brand names such as Curcuma Plus, Curcuma Plus Milk; Imboost; Fitkom; Diapet; Laxing; Lelap; Asthma Soho, and Sohobion. Its segment includes Distribution, Consumer health, Alliance, and others. The company generates maximum revenue from the Distribution segment.
Contact Information
Website
www.sohoglobalhealth.comCorporate Office
- JL. Rawa Sumur, Kav BB No. 3
- Kawasan Industri Pulogadung, Kelurahan Jatinegara, Kecamatan Cakung
- Jakarta, 13930
- Indonesia
Corporate Office
- JL. Rawa Sumur, Kav BB No. 3
- Kawasan Industri Pulogadung, Kelurahan Jatinegara, Kecamatan Cakung
- Jakarta, 13930
- Indonesia
Soho Global Health Stock Performance
As of 18-Nov-2026, Soho Global Health’s stock price is $0.06. Its current market cap is $744M with 12.7B shares.
(As of Wednesday Closing)
| Stock Price | Previous Close | 52 wk Range | Market Cap | Shares | Average Volume | EPS |
|---|---|---|---|---|---|---|
| $0.06 | $0.06 | $0.05 - $0.24 | $744M | 12.7B | 215K |
Soho Global Health Financials Summary
As of 30-Sep-2026, Soho Global Health has a trailing 12-month revenue of $645M.
|
In Thousands, USD |
TTM 30-Sep-2026 | FY 2025 31-Dec-2025 | FY 2024 31-Dec-2024 | FY 2023 31-Dec-2023 |
|---|---|---|---|---|
| EV | 873,070 | 981,898 | 471,447 | 367,190 |
| Revenue | 645,303 | 653,230 | 633,187 | 537,355 |
| EBITDA | 56,809 | 49,841 | 40,371 | 33,232 |
| Net Income | 41,683 | 36,380 | 29,126 | 24,341 |
| Total Assets | 324,315 | 367,984 | 330,891 | 304,000 |
| Total Debt | 751 | 431 | 909 | 1,277 |
Soho Global Health Valuation & Funding
| Deal Type | Date | Amount | Valuation/ EBITDA |
Post-Val | Status | Debt |
|---|
Soho Global Health Comparisons
Industry
Financing
Details
Soho Global Health Competitors (9)
One of Soho Global Health’s 9 competitors is Kimia Farma (Persero), a Corporate Backed or Acquired company based in Jakarta, Indonesia.
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| Kimia Farma (Persero) | Corporate Backed or Acquired | Jakarta, Indonesia | ||||
| Tempo Scan Pacific | Corporation | Jakarta, Indonesia | ||||
| GlaxoSmithKline Pakistan | Corporation | Karachi, Pakistan | ||||
| Kalbe Farma | Corporation | Jakarta, Indonesia | ||||
| Combiphar | Corporation | Jakarta, Indonesia |
Soho Global Health Signals
Soho Global Health ESG
Peers Analysis
Peer performance insights compare the company’s ESG performance to the performance of selected peers to help inform future ESG decisions and drive internal performance improvements.
Global
Covered Companies
Rank
Percentile
Pharmaceuticals
Industry
Rank
Percentile
Pharmaceuticals
Subindustry
Rank
Percentile
Soho Global Health FAQs
-
When was Soho Global Health founded?
Soho Global Health was founded in 1956.
-
Where is Soho Global Health headquartered?
Soho Global Health is headquartered in Jakarta, Indonesia.
-
What is the size of Soho Global Health?
Soho Global Health has 2,329 total employees.
-
What industry is Soho Global Health in?
Soho Global Health’s primary industry is Other Consumer Non-Durables.
-
Is Soho Global Health a private or public company?
Soho Global Health is a Public company.
-
What is Soho Global Health’s stock symbol?
The ticker symbol for Soho Global Health is SOHO.
-
What is the current stock price of Soho Global Health?
As of 18-Nov-2026 the stock price of Soho Global Health is $0.06.
-
What is the current market cap of Soho Global Health?
The current market capitalization of Soho Global Health is $744M.
-
What is Soho Global Health’s current revenue?
The trailing twelve month revenue for Soho Global Health is $645M.
-
Who are Soho Global Health’s competitors?
Kimia Farma (Persero), Tempo Scan Pacific, GlaxoSmithKline Pakistan, Kalbe Farma, and Combiphar are some of the 9 competitors of Soho Global Health.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process